Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Silver North Intersects 1.83 metres True Width of 1,088 g/t Silver, 3.90 g/t Gold (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Valeo Pharma Inc
VPHIF
Healthcare
Valeo Pharma Inc. is a Canadian pharmaceutical company. The Company acquires, or in-licenses branded pharmaceuticals and hospital specialty products for sale in Canada. The Company is engaged in the commercialization of prescription products in Canada with a focus on respiratory/allergy, ophthalmology and hospital specialty products. Its respiratory/allergy products include Enerzair Breezhaler,...
Atectura Breezhaler and Allerject. The ophthalmology products include Xiidra and Simbrinza. Its specialty products include Redesca, Onstryv, M-Eslon, Yondelis and Ametop Gel 4%. The Company's wholly owned subsidiary is VPI Pharmaceuticals Inc.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (GREY:VPHIF)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
Next
(5)
•••
500wedge
X
View Profile
View Bullboard History
Post by
500wedge
on Jan 02, 2021 1:39pm
Projection For 2021
With the company recently getting HC approval for a very cost effective drug, deemed best in class, and the stream of others in the 2021 pipeline, don't be shocked if they become a target from one
...more
(11)
•••
CamWisdom
X
View Profile
View Bullboard History
Comment by
CamWisdom
on Jan 02, 2021 11:10am
RE:RE:Quick summary with peak sales + margins
Look at that Redesca revenue
NurExone Biologic Secures EMA Orphan Status for ExoPTEN in Spinal Cord Injury, Accelerating Pathway to European Markets
posted Nov 14, 2024 9:00am by
NurExone Biologic Inc.
-
|
“We are honored by the EMA’s recognition of ExoPTEN through the Orphan Medicinal Product Designation, which significantly advances our ability to enter the European market and offers hope to those impacted by acute spinal cord injuries,” said Dr. Lior Shaltiel, Chief Executive Officer of NurExone. “This designation, together with the ...read more
(13)
•••
Indajungle1
X
View Profile
View Bullboard History
Comment by
Indajungle1
on Jan 01, 2021 9:56pm
RE:Quick summary with peak sales + margins
Problem posting it ... hoping the link works https://cdn-ceo-ca.s3.amazonaws.com/1fu557g-Screenshot%202020-12-22%20at%207.52.32%20PM.png
(13)
•••
Indajungle1
X
View Profile
View Bullboard History
Post by
Indajungle1
on Jan 01, 2021 9:52pm
Quick summary with peak sales + margins
(11)
•••
CamWisdom
X
View Profile
View Bullboard History
Post by
CamWisdom
on Dec 30, 2020 5:29pm
Full of potential
2021 looks bright here - Cam
(328)
•••
eric_a_su
X
View Profile
View Bullboard History
Post by
eric_a_su
on Dec 22, 2020 7:26pm
new video interview
(103)
•••
ThisIsYerChance
X
View Profile
View Bullboard History
Comment by
ThisIsYerChance
on Dec 17, 2020 12:27pm
RE:Nice Write Up
So....this is yer chance?
(5)
•••
500wedge
X
View Profile
View Bullboard History
Post by
500wedge
on Dec 17, 2020 10:52am
Nice Write Up
https://agoracom.com/ir/ValeoPharma/forums/discussion/topics/751140-agoracom-welcomes-valeo-pharma-vph-cse-vphif-otcqb-with-7-products-to-be-launched-in-2021-2022-45m-estimated-peak-sales-year
...more
(84)
•••
Yamana
X
View Profile
View Bullboard History
Post by
Yamana
on Dec 11, 2020 6:30pm
Valeo Continues to Execute on In-Licensing Strategy;coverage
Health Canada Issues Notice of Compliance for REDESCA, Valeo Pharma Continues to Execute on In-Licensing Strategy Weekend Market Bulletin issued this pm: https://marketequitiesresearch.com
...more
(21)
•••
eric40
X
View Profile
View Bullboard History
Comment by
eric40
on Dec 10, 2020 8:01pm
RE:RE:Rock and Roll
Redeska approval is big awaited news that will a a dramatic impact on 2021 and future revenu. As a generic heparin, the only one available, provinces where it is mandatory to buy generic first if
...more
(51)
•••
kooter33
X
View Profile
View Bullboard History
Comment by
kooter33
on Dec 10, 2020 12:22pm
RE:Rock and Roll
A lot depends on the Xmas selling. People may take profits to fund their Xmas. Also depends on VPH management releasing any additional NRs before Xmas. If they decide to wait until
...more
(9)
•••
NAGGY23
X
View Profile
View Bullboard History
Post by
NAGGY23
on Dec 09, 2020 10:53pm
Rock and Roll
VPH will be 1.50 to $1.75 by end of month ..
(51)
•••
kooter33
X
View Profile
View Bullboard History
Comment by
kooter33
on Dec 09, 2020 6:34pm
RE:I ignored the noise and bought more on the dip
Yup! 56.8M shares outstanding and 54% of those are with insiders and employees of the company. So leaves for a pretty small float. The last PP was oversubscribed. CFO indicated
...more
(8)
•••
FOMOalpha
X
View Profile
View Bullboard History
Post by
FOMOalpha
on Dec 09, 2020 4:58pm
I ignored the noise and bought more on the dip
Sell-off on news is kinda expected but admittedly I didn't expect such a drastic drop but that is also one of many scenarios I think could happen given that VPH is a stock with a small float. It
...more
(51)
•••
kooter33
X
View Profile
View Bullboard History
Comment by
kooter33
on Dec 09, 2020 4:30pm
RE:Garbage Stock
Higher highs and higher lows. Buy the rumour, sell the news. That is what you saw today. 1/2 of the trades were bought today above yesterday's close $1.27. Institutes were
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Geodrill Generates Revenue of $34.1M, a 13% Increase Compared to $30.3M for Q3-2023
Gold, growth and sustainability in focus for this resource company
Star Diamond Corporation Announces Third Quarter 2024 Results
Coppernico Drills 19 Meters of 0.50% Copper in First 5 Holes and Applies for Additional Permits
Explained: The Psychology of Options Trading with Practical Tips
Meet the Top 5 Best Online Brokerages in Canada
Major Funding Secured! Company Closes First Round of Private Placement
Have you held units of a TD mutual fund (other than through a discount broker)? Learn more.